+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Multimodal Imaging Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 198 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968791
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Multimodal imaging is accelerating the digital transformation of healthcare, equipping organizations to make better clinical and operational decisions while adapting to emerging trends. As senior leaders face rapid industry evolution, incorporating these advanced imaging technologies is essential to sustain competitiveness and care quality.

Market Snapshot: Multimodal Imaging Market Size, Growth, and Outlook

The global multimodal imaging market is currently valued at USD 3 billion and is projected to reach USD 3.19 billion by 2025, reflecting a compound annual growth rate of 6.37%. This growth is driven by continuous innovation in hybrid imaging systems, robust modernization of healthcare infrastructure, and wider adoption across multiple clinical specializations. Strategic investment in digital capabilities and cross-sector collaboration is advancing the geographic reach of these solutions. Organizations are leveraging these trends to align with new care models and remain agile amid regulatory and technology-driven changes, strengthening long-term resilience in an evolving market landscape.

Scope & Segmentation of the Multimodal Imaging Market

  • Component: Hardware, software, and service solutions form the foundation of resilient imaging platforms. These components are engineered for secure data transfers, platform reliability, and enhanced collaboration among healthcare providers and research teams.
  • Imaging Modality: Integrated PET CT, PET MR, and SPECT CT systems combine anatomical and functional imaging. These modalities enable more precise diagnostics, facilitate early detection, and optimize complex treatment strategies in patient care.
  • Application: Utilization spans cardiology, neurology, and oncology, where multimodal imaging improves patient stratification, enables comprehensive disease monitoring, and supports evidence-based clinical decision-making across health systems.
  • End User: Hospitals, clinical centers, research institutes, and academic organizations rely on these imaging solutions to drive innovation, support cutting-edge research, and deliver superior standards of care. Broader adoption is increasing knowledge-sharing and advancing research excellence across regions.
  • Regions: Americas, Europe, Asia-Pacific, Middle East, and Africa each display distinct adoption patterns influenced by regulatory requirements and the maturity of digital infrastructure. Understanding varied regional priorities is vital for shaping effective strategy and ensuring sustainable market entry.
  • Companies Analyzed: Industry leaders such as General Electric Company, Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, and Fujifilm Holdings Corporation play a pivotal role in setting industry benchmarks. Contributions from PerkinElmer, Inc., Bruker Corporation, United Imaging Healthcare Co., Ltd., Mediso Medical Imaging Systems Ltd., and MR Solutions Ltd. underscore ongoing commitments to innovation and quality in the global market.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Unified imaging workflows are bridging data silos between clinical specialties, enabling organizations to streamline collaboration and support transition to value-based care delivery models.
  • Continued advances in detection and signal-processing technology deliver rapid, accurate diagnostics that support evolving clinical needs and improve patient outcomes across diverse populations.
  • Artificial intelligence tools are strengthening regulatory compliance and operational efficiency by optimizing resource allocation and enabling more informed, timely clinical decisions.
  • Hybrid system flexibility is driving the development of personalized therapies, adaptable monitoring solutions, and continuous alignment with changing clinical and research requirements.
  • Collaborative engagements among technology vendors, researchers, and pharmaceutical partners are expanding secure interoperability and facilitating the development of novel imaging agents critical to innovation pipelines.
  • Comprehensive supply chain strategies mitigate regulatory exposure, strengthening operational continuity and ensuring organizations can adapt proactively to shifting market environments.

Assessing Tariff Impact: 2025 Developments and Industry Response

New US tariffs are currently shaping procurement strategies across the multimodal imaging sector. Key industry stakeholders are prioritizing engagement with regional suppliers, diversifying manufacturing locations, and deepening local partnerships. These adaptive responses support sustained supply stability and operational resilience, helping organizations navigate regulatory changes while maintaining strategic priorities.

Methodology & Data Sources

This report employs a rigorous methodology, drawing on published market research, detailed reviews of relevant patents, financial analysis, and direct consultation with key industry stakeholders. The assessment integrates SWOT and PESTEL frameworks to ensure in-depth evaluation of regulatory impacts and the trajectory of advanced technology adoption within the sector.

Why This Report Matters: Actionable Intelligence for Senior Leaders

  • Provides actionable recommendations for focused capital investment and effective technology alignment, supporting future-ready growth and operational initiatives.
  • Highlights practical advantages of digital workflow innovation and artificial intelligence integration, empowering teams to streamline processes and achieve better clinical and organizational outcomes.
  • Delivers up-to-date leadership insight on market dynamics, compliance obligations, and technology shifts so organizations remain agile in the face of regulatory and technological disruption.

Conclusion

Senior executives using this report gain the clarity needed to lead digital transformation, foster sustainable expansion, and secure strengthened competitive positioning amid ongoing changes in the healthcare sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. AI driven fusion of PET and MRI data for enhanced cancer diagnosis and monitoring
5.2. Emergence of handheld ultrasound and photoacoustic imaging platforms for point of care diagnostics
5.3. Integration of real time MRI and EEG modalities for advanced functional brain mapping in neuroscience research
5.4. Development of multimodal optical coherence tomography combined with fluorescence for intraoperative tumor margin detection
5.5. Commercialization of dual modality PET/CT scanners with deep learning enhancement in oncology workflows
5.6. Adoption of hyperspectral imaging fused with MRI for improved tissue classification in preclinical studies
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Multimodal Imaging Market, by Component
8.1. Hardware
8.2. Services
8.3. Software
9. Multimodal Imaging Market, by Modality
9.1. PET CT
9.2. PET MR
9.3. SPECT CT
10. Multimodal Imaging Market, by Application
10.1. Cardiovascular
10.2. Neurology
10.3. Oncology
11. Multimodal Imaging Market, by End User
11.1. Academic Institutes
11.2. Diagnostic Imaging Centers
11.3. Hospitals
11.4. Research Institutes
12. Multimodal Imaging Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Multimodal Imaging Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Multimodal Imaging Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. General Electric Company
15.3.2. Siemens Healthineers AG
15.3.3. Koninklijke Philips N.V.
15.3.4. Canon Medical Systems Corporation
15.3.5. Fujifilm Holdings Corporation
15.3.6. PerkinElmer, Inc.
15.3.7. Bruker Corporation
15.3.8. United Imaging Healthcare Co., Ltd.
15.3.9. Mediso Medical Imaging Systems Ltd.
15.3.10. MR Solutions Ltd.

Companies Mentioned

The companies profiled in this Multimodal Imaging market report include:
  • General Electric Company
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • PerkinElmer, Inc.
  • Bruker Corporation
  • United Imaging Healthcare Co., Ltd.
  • Mediso Medical Imaging Systems Ltd.
  • MR Solutions Ltd.

Table Information